PYC Therapeutics Limited
PYC Therapeutics Limited, often referred to as PYC, is an innovative biotechnology company headquartered in Australia. Founded in 2017, PYC focuses on developing transformative RNA-targeted therapies for genetic disorders, positioning itself at the forefront of the biotechnology industry. With a commitment to addressing unmet medical needs, PYC Therapeutics has made significant strides in its research and development efforts, particularly in the field of RNA therapeutics. The company’s core products, which include proprietary RNA-targeted drug candidates, are designed to offer unique solutions for conditions caused by genetic mutations. PYC's dedication to advancing therapeutic options has garnered recognition within the industry, establishing it as a notable player in the biotechnology landscape. As it continues to expand its operational reach, PYC Therapeutics remains committed to innovation and improving patient outcomes globally.
DitchCarbon Score
How does PYC Therapeutics Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
PYC Therapeutics Limited's score of 14 is lower than 93% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
PYC Therapeutics Limited's reported carbon emissions
PYC Therapeutics Limited, headquartered in Australia, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and commitments suggests that PYC Therapeutics may not yet have established a formal framework for addressing its carbon footprint or climate impact. In the context of the biotechnology industry, many companies are increasingly adopting science-based targets and sustainability initiatives to mitigate climate change. However, without specific commitments or emissions data, PYC Therapeutics' position on climate action remains unclear. As the industry evolves, it will be essential for the company to consider implementing strategies to measure and reduce its environmental impact.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
PYC Therapeutics Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
